Metabolic dysfunction-associated steatohepatitis+1
Not recruitingStudy on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis
Study on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis
- Disease:Metabolic dysfunction-associated steatohepatitisNon-alcoholic steatohepatitis
- Substances:EfinopegdutideSemaglutide
Spain- Participants:18–64 years · 65+ years
- Substances:Efinopegdutide
- Sponsor:Merck Sharp & Dohme LLC















